TTX 334 Endometriosis

What if an antigen were expressed in both malignant (ovarian) and benign (endometriosis and fibrotic) tissues yet on the cell surface of normal cells it is absent?

What if this antigen was a key mechanistic player for cell survival?

What would it mean if the therapeutics candidate TTX334 could reduce endometriosis tissue while leaving healthy tissue unharmed?  Read more...

 

 

 

 

Preclinical Results TTX 334 Endometriosis

MeEt Us

View our upcoming events

View All Events